Pharma logistics are expected to look significantly different by 2030 as networks evolve into a strategic capability that connects manufacturing, clinical research, healthcare providers, regulators and patients through real-time visibility, coordination and decision-making. At the same time, the therapies moving through supply chain networks are fundamentally changing, requiring special handling and sophisticated coordination. This playbook explores how these shifts have led to the development of health chain orchestration, a model for moving pharma products that transcends logistics. For biopharma leaders, the implications extend far beyond transportation. Highlights include: The global volatilities that forced traditional models to evolve. What collaborative logistics look like and how coming pharmaceutical regulations raise the stakes. How unprecedented amounts of information generated by supply chains can shift logistics from a support function to a strategic differentiator.
